TYSONS, VA–(April 15, 2026) – Millions of Americans are living with chronic conditions that biotechnology can treat, or even cure. Millions more are still waiting.
Today, WHITE64 and the Biotechnology Innovation Organization (BIO) launched “The Fight of Our Lives,” a national campaign designed to spotlight what’s at stake when scientific progress is slowed, and who stands to benefit when it moves forward.
With Creative developed by WHITE64, the campaign seeks to elevate public understanding of biotechnology’s real-world impact, shifting the conversation from abstract science and policy debate to the people whose lives and livelihoods depend on continued innovation. At a time when political and public skepticism continues to influence the pace of progress, the work reframes biotechnology as essential to improving quality of life, extending time with loved ones, and creating better outcomes for patients and their families.
Launching April 15 and running for an initial three-year term, the campaign will roll out across CTV, radio, print, digital, and direct-to-publisher placements, including Axios and Politico.
The first phase of the campaign, running through Fall 2026, features a series of real-life patient and researcher stories. Through the theme “The Fight of Our Lives,” the vignettes spotlight patients, families, researchers, and entrepreneurs, sharing their true stories. From the individuals behind the life-changing science to the people whose lives are transformed, these stories illustrate how American biotechnology is helping treat disease, improve quality of life, support families, and drive the scientific breakthroughs shaping a healthier future.
“This campaign is an appeal to policymakers to put patients first and protect and invest in biotechnology innovation,” said Sarah Alspach. “For every biotechnology breakthrough, there is a patient and family who get their quality of life back, a second chance, or an opportunity to spend more time together.”
“There’s a tendency to talk about biotech in terms of future cures,” said Heather Knight, Vice President and Group Creative Director at WHITE64. “But for millions of people, this isn’t theoretical, it’s about improving the life they’re living right now. We built this campaign to make that reality impossible to overlook.”
WHITE64 has partnered with BIO for more than a decade. Most recently, the agency developed a 2025 campaign focused on maintaining vaccination standards in the U.S., which continues to run in the Washington, D.C., market.
About WHITE64
WHITE64 is a creative agency based in Tysons, Virginia, working with service-driven brands across financial services, travel and tourism, government contracting, healthcare, and associations. The agency specializes in brand, advertising, content, video production, paid media, and digital experiences, helping organizations that feel like the “best kept secret” stand out with work that is heard, seen, and felt.
